| Date | Description |
| 27 July 2010 | Sanofi-aventis and Merck appoint Raul Kohan as CEO for the new Animal Health joint ventureParis, France and Whitehouse Station, NJ – July 27, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Merck & Co., Inc. (NYSE: MRK) announced today that Raul E. Kohan will be appointed Chief ... |
| 22 July 2010 | Intervet/Schering-Plough Animal Health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swineSimultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and ... |
| 23 June 2010 | Deltamethrin-impregnated collar provides a cost-effective solution to control canine and human LeishmaniasisBOXMEER (The Netherlands) June 23, 2010 - Delegates at the 2nd International Congress on Canine Leishmaniasis, which was recently held in the Italian city of Pisa, heard how a readily-available deltamethrin-impregnated ... |
| 22 June 2010 | Intervet/Schering-Plough Animal Health receives positive opinion in Europe for simultaneous use of PORCILIS PRRS and PORCILIS M Hyo vaccines in pigletsBOXMEER (the Netherlands), June 22, 2010 – Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency ... |
| 9 June 2010 | Dieter Lütticken Award 2009 for development of in vitro bovine respiratory tract organ culture modelBOXMEER (Netherlands), June 9, 2010 – The Dieter Lütticken Award 2009, a prestigious international annual award dedicated to alternatives in animal testing for veterinary medicines, goes to Dr. A.W. (Dan) ... |
| 1 June 2010 | Equine strangles vaccine returns to the market in EuropeBOXMEER (the Netherlands), June 1, 2010 – Intervet/Schering-Plough Animal Health, the European market leader in equine vaccines, today announces that it is re-introducing EQUILIS® StrepE, the only strangles ... |
| 27 May 2010 | Study shows cost-effectiveness of RESFLOR in feedlot cattle treated for undifferentiated fever related to Bovine Respiratory DiseaseBOXMEER (Netherlands), May 27, 2010 – In a Canadian field trial in feedlot cattle recently published in Veterinary Therapeutics, it was demonstrated that treatment of undifferentiated fever related to ... |
| 10 May 2010 | Intervet/Schering-Plough Animal Health introduces the SLICE Sustainability Project at Sea Lice 2010BOXMEER (The Netherlands), May 10, 2010 — Intervet/Schering-Plough Animal Health has introduced the SLICE® Sustainability Project, a comprehensive, six-step integrated strategy to help the world’s salmon ... |
| 29 April 2010 | Pancreatic disease vaccine patent of Intervet/Schering-Plough Animal Health upheld by Oslo District CourtBOXMEER (Netherlands) and OSLO (Norway), April 29, 2010 – Intervet/Schering-Plough Animal Health announces today that the Oslo District Court has ruled that its Pancreatic Disease (PD) patent NO 317.547 ... |
| 22 April 2010 | Intervet/Schering-Plough Animal Health opens state-of-the-art vaccine manufacturing facility at Biosciences Center BoxmeerBOXMEER (Netherlands), April 22, 2010 – Intervet/Schering-Plough Animal Health announces that it will open today a state-of-the-art production center for veterinary vaccines against bacterial infections. ... |
| 1 April 2010 | Consortium receives research grant from the Wellcome Trust to develop improved vaccines against foot-and-mouth diseaseBOXMEER (Netherlands), April 1, 2010 – An international collaborative group of research institutions and industry today announces that it has received approximately US$ 2 million from the Wellcome Trust ... |
| 19 March 2010 | Broadcasting website offers dairy professionals virtual presence at international mastitis conference in New ZealandBoxmeer, March 19, 2010 - Intervet/Schering-Plough Animal Health launches the website Studio Recharge, broadcasting to the global dairy community from the 5th International Dairy Federation (IDF) Mastitis ... |
| 9 March 2010 | Sanofi-aventis and Merck to create a Global Leader in Animal HealthSanofi-aventis exercises its option to combine Merial with Intervet/Schering-Plough in a new equally-owned Joint Venture with MerckParis, France and Whitehouse Station, NJ. – March 9, 2010 – Sanofi-aventis ... |
| 27 January 2010 | Intestinal Health Center for Poultry website offers rich content, dynamic featuresBOXMEER (Netherlands), January 27, 2010 – Intervet/Schering-Plough Animal Health has launched the Intestinal Health Center for Poultry website (www.ihc-poultry.com), a dedicated website to keep producers, ... |
| 26 January 2010 | Intervet/Schering-Plough Animal Health receives European approval for a single-shot dosage scheme of PORCILIS PCVBOXMEER (Netherlands), January 26, 2010 – Intervet/Schering-Plough Animal Health today announces that it has received marketing authorization from the European Commission on January 12, 2010 for a single-shot ... |
| 13 January 2010 | Symposium shows importance of managing Bovine Respiratory Disease 'right first time' with combination treatmentBOXMEER (Netherlands), January 13, 2010 – Treatment of Bovine Respiratory Disease (BRD) in cattle with a combination preparation consisting of the anti-infective drug florfenicol and the anti-inflammatory ... |
